Cleveland Clinic breast specialists have made enormous progress in the prevention, diagnosis and treatment of breast cancer. More women than ever before are winning the fight because of improvements in prevention and detection and the advances in treatment options and services available.
One of the most important advances is the ability to tailor treatment based on the risks and benefits for a specific patient, which could lead to better outcomes and fewer side effects.
Cleveland Clinic breast specialists have have made great strides in the hopes of beating breast cancer, but there is still great room to grow.
Cancer clinical trials offer patients important treatment options and access to the latest treatments and procedures resulting from cancer research. Participation in clinical trials also helps scientists and researchers advance the cause of preventing, diagnosing and treating cancer.
A breast imaging study exploring potential technology that may improve the accuracy of breast cancer diagnosis and help women with benign masses avoid invasive biopsies.
For patients 18 years and older who have newly discovered suspicious breast masses seen by ultrasound. The study will compare traditional imaging with a new imaging technology. Patients are followed for a year and return for another scan in one year, unless they have a biopsy.
For more information about clinical research studies, please contact us: 216.636.5340.
Find more clinical trials:
Possible Breast Cancer Vaccine»
Researchers at Cleveland Clinic’s Lerner Research Institute found that a single vaccination could prevent breast tumors from occurring in mice genetically bred to develop breast cancer, while also inhibiting the growth of already existing breast tumors. The research program is lead by Dr. Vincent Tuohy, PhD. The research was published in 2010 in the journal Nature Medicine.
Intraoperative Radiation Therapy»
Intraoperative Radiation Therapy (IORT) is a new, one-time procedure option for beast cancer that combines both surgery and radiation. Candidates for this type of treatment are patients over 60 with early stage breast cancer.